
    
      This is a multicenter (when more than one hospital or medical school team work on a medical
      research study) study which includes an initial unmasked safety phase. The duration of
      participation in the study for each participant is approximately 3 years. Efficacy will be
      evaluated at 6 months, 12 months and annually thereafter. Participants' safety will be
      monitored throughout the study.
    
  